Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy

Abstract

Immune checkpoint inhibitors (ICI) may have unanticipated side effects in transplant recipients who subsequently develop tumors. Here the authors used single-cell sequencing to identify and characterize allogeneic reactive T cells that developed after an ICI course for melanoma in a transplant recipient.